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Microcirculation in STEMI 
Background 
Background 
P-PCI for STEMI – Some patients do well… 
Background 
… while others don’t… 
Background 
A significant proportion of STEMI patients (from 20% to 60%) has a poor 
outcome because of microvascular coronary damage. 
 
The negative prognostic implications (both on the risk of LV remodeling and 
on the risk of hard endpoints, including death) associated with coronary 
microvascular damage has been repeatedly confirmed, with several invasive 
and non-invasive indicators 
 
Several mechanisms proposed: 
• Mechanical obstruction (due to distal embolization of atherothrombotic 
debris) 
• Coronary endothelial dysfunction (mediated by the release of vasoactive 
factors, like endothelin-1 and tissue factor) 
• Reperfusion injury (through several mechanisms) 
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Background 
Peripheral arterial tonometry (PAT) 
Non-invasive evaluation of endothelial function  
 
• Noninvasive measurement of endothelial-dependent vasodilator 
function in the microcirculation of the finger. 
• Pulse amplitude in the fingertip measured at rest and following the 
induction of reactive hyperemia. 
 
EndoPAT 2000 
(Itamar Medical, Caesarea, Israel) 
Bonetti P et al. J Am Coll Cardiol 2003;41(10):1761–8.  
Background 
Peripheral arterial tonometry (PAT) and coronary endothelial function 
Bonetti P. et al. J Am Coll Cardiol 2004;44:2137 
Non-invasive evaluation of endothelial function  
 
• Endothelial-dependent dysfunction evaluated by PAT is correlated with 
coronary microvascular dysfunction in stable patients 
 
 
 
 • 94 patients with non-obstrutive 
CAD 
 
• Invasive evaluation of coronary 
endothelial function (acetylcholine) 
 
• endoPAT evaluation 
IHR<1,67 
Sensitivity 80%  
Specificity 85% 
Background 
Peripheral arterial tonometry (PAT) and extent of infarction in 
patients with STEMI 
Baptista SB et al. Microvascular Research 105 (2016); 34-39 
Endothelial dysfunction in CAD patients 
Background 
Peripheral arterial tonometry (PAT) and extent of infarction in 
patients with STEMI 
Baptista SB et al. Microvascular Research 105 (2016); 34-39 
Endothelial dysfunction in CAD patients 
• Endothelial dysfunction evaluated by RHI-PAT relates with the extension 
of myocardial infarction (P-PCI treated) measured by peak TnI  
• 58 primary PCI patients 
• Peak TnI 
• EndoPAT evaluation 
RHI-PAT <1,67  = only 
variable related with peak 
TnI on multivariate 
analysis 
73.5 (107.1) 
35.2 (64.3) 
p=0.028  
Background 
Peripheral arterial tonometry (PAT) and severity of CAD 
Baptista SB. J Am Coll Cardiol. 2013; 62(18_S1):B183-B183 
Endothelial dysfunction in CAD patients 
• Endothelial-dependent dysfunction evaluated by RHI-PAT relates it the 
severity of CAD disease  
• 231 CAD patients 
 
• Angiography performed 
 
• endoPAT evaluation 
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“Normal” 
coronaries 
3 vessels 
disease 
1,98 ± 0,46  
1,85 ± 0,45 
1,60 ± 0,39 
RHI-PAT = only predictor of 
3 vessel disease on 
multivariate analysis 
Background 
Index of microvascular resistance (IMR) 
Invasive evaluation of microvascular coronary circulation 
 
Microcirculation in STEMI 
Study Objectives 
Purpose 
Study Hypothesis and Aims 
Study hypothesis 
• In patients with acute STEMI treated with primary PCI, endothelial 
dysfunction (evaluated by peripheral arterial tonometry) is related to the 
extent of microvascular damage and, consequently, to the extent of 
myocardial necrosis. 
Study aims 
• Primary aim: To evaluate the relation between endothelial dysfunction 
(evaluated with EndoPAT) and coronary microvascular dysfunction 
(evaluated by IMR) immediately after primary PCI. 
• Secondary aims: Confirming IMR and evaluating endothelial dysfunction 
(as measured by peripheral arterial tonometry) as predictors of 
microvascular dysfunction and extension of the myocardial infarction. 
 
Purpose 
Study outcome measures 
Primary outcome measures 
• IMR value in patients with endothelial dysfunction (RHI  <1.67) 
• IMR value according to the tertile of RHI  
Secondary outcome measures 
1. The relation between RHI values and:  
• The extent of myocardial necrosis 
• The extent of coronary microvascular obstruction 
2. The relation between IMR values and: 
• The extent of myocardial necrosis 
• The extent of coronary microvascular obstruction 
Microcirculation in STEMI 
Population and Methods 
Results Methods 
Population 
Type of Study 
Observational, prospective, single centre, cohort study, performed in the 
Cardiology Department of Hospital Prof. Doutor Fernando da Fonseca 
(Amadora, Portugal). 
Population 
Patients admitted to Hospital Prof. Doutor Fernando da Fonseca with a first 
acute ST elevation myocardial infarction, treated with primary angioplasty 
Results Methods 
Population 
Inclusion Criteria 
• Age > 18 years 
• ST elevation (first) myocardial infarction defined as: 
- Thoracic pain with ≥ 20 min and/or  
- ST elevation ≥1 mm in two or more contiguous ECG leads 
• Time pain-to-balloon < 6 hours (or between 6 and 12 horas, if pain 
clearly persists) 
• Successful PCI of the culprit artery (no significant residual lesion, 
independently of the final TIMI flow) in a native coronary artery 
• Informed consent obtained 
Results Methods 
Population 
Exclusion Criteria 
• LBBB or pacemaker 
• Previous myocardial infarction (STEMI or nSTEMI) 
• Killip class IV 
• PCI in the previous 3 months or previous CABG (anytime) 
• Long-QT syndrome, 2nd or 3rd degree AV block, sinus node disease 
• Arrhythmias considered by the investigator to contra-indicate 
adenosine 
• Severe asthma or COPD 
• Previous severe side effects to adenosine or other contra-indication 
for adenosine use 
• Life expectancy <12 month 
• Inclusion in other trials 
Results Methods 
Peripheral arterial tonometry (PAT) 
Non-invasive evaluation of endothelial function  
• PAT probe positioned in one finger of each hand 
• Blood pressure cuff is inflated on one arm to suprasystolic pressures for 
5 minutes.  
Bonetti P et al. J Am Coll Cardiol 2003;41(10):1761–8.  
Results Methods 
Index of microvascular resistance (IMR) 
Invasive evaluation of microvascular coronary circulation 
• Immediately after successful PCI of the culprit artery 
• Certus Pressure-Wire® (St. Jude Medical)  
• RadiAnalyzer Xpress (St. Jude Medical®) 
• Maximal hyperemia obtained with adenosine (perfusion by central or 
large peripheral vein) 
Results Methods 
Index of microvascular resistance (IMR) 
Fearon WF et al. J Am Coll Cardiol 2008;51(5):560–5 
Invasive evaluation of microvascular coronary circulation 
 
Results Methods 
Infarct extension evaluation 
Troponin I release 
• Dimension Vista™ Intelligent Lab System, Siemens Healthcare 
Diagnostics™ 
• Blood samples collected at admission, 6, 12, 18, 24, 36 and 48h 
• Peak TnI values and the area under the curve (AUC) of TnI release 
Echocardiography 
• Performed in the first hours after P-PCI and at 3 months 
• LV volumes, LVEF, WMSI and global longitudinal strain 
Contrast enhanced cardiac magnetic resonance (ceCMR) 
• Performed on the 7-8th day post-MI 
• 1.5-T MRI system (Avanto, Siemens Medical System, Erlangen, 
Germany)  
• Infarct size, percent of infarct size  
Results Methods 
Coronary microvascular obstruction evaluation 
ECG ST-elevation resolution 
• ECGs collected before, immediately after/90 min/180 min after P-PCI 
• % of total ST-elevation resolution was calculated vs. pre-PCI ECG 
Angiographic indicators (measured at the end of the procedure) 
• Corrected TIMI frame count (cTFC) 
• TIMI myocardial perfusion grade (MPG) 
Contrast enhanced cardiac magnetic resonance (ceCMR) 
• Presence of microvascular obstruction (no reflow) 
• Mass of microvascular obstruction 
Microcirculation in STEMI 
Results 
Results 
Included population 
N: 60 patients 
Mean age: 59.6±12.7 years 
Culprit Artery 
28 (46.7%) 
19 (31.7%) 
13 (21.7%) 
LAD 
LCx RCA 
Time Delays  
 
  Pain-to-balloon time: 209 (IQR 148) min 
  Door-to-balloon time: 78 (IQR 45) min  
 
Primary PCI 
 
  Abciximab: 14 (23.3%) 
  Mechanical thrombectomy: 26 (43.3%) 
  Stent: 57 (95.0%) 
  Direct stenting: 25 (41.7%) 
  Post-dilatation: 28 (38.3%) 
 
Hypertension: 43 (71.7%) 
Diabetes: 15 (25.0%) 
Dyslipidemia: 30 (50.0%) 
Smoking habits: 26 (43.3%) 
Main Epidemiological characteristics 
Results 
Index of microvascular resistance (IMR) 
Median value: 
23.9 (IQR 32.9) 
Results 
Peripheral arterial tonometry (EndoPAT) 
B A RHI = 2.14 RHI = 1.40 
Example 1 
Patient with normal endothelial function 
Example 2 
Patient with endothelial dysfunction 
Examples of normal and abnormal results 
Results 
Peripheral arterial tonometry (EndoPAT) 
Reactive hyperaemia index (RHI) values on the 1st and 2nd EndoPAT 
1st EndoPAT 
1st EndoPAT in patients 
with 2nd EndoPAT 
2nd EndoPAT p valuec 
N 60 38 38 
RHI a 2.15±0.58 2.16±0.52 1.87±0.60 0.006  
Endothelial dysfunction 
(RHI<1.67)b 
11 (18.3) 6 (15.8) 16 (42.1) 0.011  
L_RHI a 0.73±0.28 0.74±0.24 0.61±0.25 0.006  
a Presented as mean±standard deviation; b Presented as N(%). C p-value for the comparison between first and second 
EndoPAT only in patients with 2 evaluations; paired samples T-Test for continuous variables and Chi-square test for 
categorical variables; RHI: reactive hyperaemia index; L_RHI: logarithmic RHI. 
Results 
Outcome measures 
Primary outcome measures 
• IMR value in patients with endothelial 
dysfunction (RHI  <1.67) 
• IMR value according to the tertile of RHI  
Secondary outcome measures 
1. The relation between RHI values and:  
• The extent of myocardial necrosis 
• The extent of coronary microvascular 
obstruction 
2. The relation between IMR values and: 
• The extent of myocardial necrosis 
• The extent of coronary microvascular 
obstruction 
In the 1st 
EndoPAT 
(acute) 
In the 2nd 
EndoPAT 
(24-h) 
Results 
Outcome measures 
Primary outcome measures 
• IMR value in patients with endothelial 
dysfunction (RHI  <1.67) 
• IMR value according to the tertile of RHI  
In the 1st 
EndoPAT 
(acute) 
In the 2nd 
EndoPAT 
(24-h) 
Results 
24.0 [31.2] 16.0 [37.3] 
Primary Outcome – IMR and RHI values 
IMR values according to the presence of ED (RHI<1.67) 
Presented as Median [Interquartile Range] 
Mann-Whitney test 
22.0 [26.0] 
40.5 [54.4] 
Endothelial 
dysfunction present in 
11/60 patients (18.3%) 
Endothelial 
dysfunction present in 
16/38 patients (42.1%) 
1st EndoPAT 2nd EndoPAT 
p = 0.17 p = 0.09 
Results 
19.4 [32.9] 40.5 [31.2] 23.3 [30.3] 
Primary Outcome – IMR and RHI values 
IMR values according to tertiles of RHI 
Presented as Median [Interquartile Range] 
Kruskal-Wallis test 
1st EndoPAT 2nd EndoPAT 
p = 0.26 p = 0.64 
39.0 [43.4] 23.8 [42.5] 19.5 [30.6] 
Results 
Outcome measures 
Primary outcome measures 
• IMR value in patients with endothelial 
dysfunction (RHI  <1.67) 
• IMR value according to the tertile of RHI  
Secondary outcome measures 
1. The relation between RHI values and:  
• The extent of myocardial necrosis 
In the 1st 
EndoPAT 
(acute) 
In the 2nd 
EndoPAT 
(24-h) 
Results 
Secondary Outcomes (1st EndoPAT) 
Endothelial dysfunction and extent of myocardial infarction 
Variable 
Total 
Population 
Endothelial Dysfunction (RHI<1.67) 
p value 
No (n=49) Yes (n=11) 
Troponin Release 
   TnIpeak  
a 117±82 117±87 115±55 0.96 
   TnIAUC  
a 1938±1283 1951±1376 1883±787 0.88 
Echocardiography (n=40 for GLS)   
   LVEF (%)a 47.9±6.7 47.9±6.8 47.8±5.9 0.96 
   Wall motion score index b 1.41 (0.35) 1.41 (0.35) 1.53 (0.18) 0.78 
   Global longitudinal strain a -13.54±2.28 -13.38±2.30 -14.7±1.96 0.23 
ceCMR (n=49)         
   LVEF (%)a 53.6±8.7 53.9±8.7 52.4±9.3 0.62 
   Wall motion score index a 1.42±0.29 1.41±00.30 1.46±0.23 0.64 
   Transmural necrosis c 23 (46.9) 18 (46.2) 5 (50.0) 0.89 
   Infarct mass b 14.7 (12.6) 11.7 (9.8) 19.9 (11.9) 0.11 
   Percent infarct mass b 12.6 (14.4) 11.6 (12.9) 20.3 (14.5) 0.08 
     Indexed to BARI score b  3.8 (4.3) 3.0 (3.6) 5.5 (5.1) 0.07 
a Presented as mean±standard deviation; b Presented as median (interquartile range);  c Presented as number (%); 
Results 
Secondary Outcomes (2nd EndoPAT) 
Endothelial dysfunction and extent of myocardial infarction 
Variable 
Total 
Population 
Endothelial Dysfunction (RHI<1.67) 
p value 
No (n=22) Yes (n=16) 
Troponin Release 
   TnIpeak  
b 95 (96) 67 (81) 118 (186) 0.024 
   TnIAUC  
b 1293 (1580) 1076 (1042) 2305 (2486) 0.012 
Echocardiography (n=21 for GLS)         
   LVEF (%)a 48.6±7.1 51.4±4.7 45.3±8.3 0.045 
   Wall motion score index b 1.44 (0.41) 1.35 (0.47) 1.77 (0.47) 0.006 
   Global longitudinal strain a -13.16±2.35 -14.32±1.72 -11.89±2.35 0.014 
ceCMR (n=29)         
   LVEF (%)a 53.9±8.4 56.6±8.1 49.5±7.2 0.025 
   Wall motion score index a 1.37±0.33 1.28±0.31 1.53±0.32 0.05 
   Transmural necrosis c 12 (38.7%) 4 (22.2%) 7 (63.6%) 0.06 
   Infarct mass b 11.6 (9.3) 10.1 (10.3) 17.5 (15.4) 0.08 
   Percent infarct mass b 11.5 (13.7) 10.2 (7.6) 17.5 (21.8) 0.10 
     Indexed to BARI score b 3.4 (5.8) 2.3 (2.7) 5.1 (11.5) 0.09 
a Presented as mean±standard deviation; b Presented as median (interquartile range);  c Presented as number (%); 
Results 
Outcome measures 
Primary outcome measures 
• IMR value in patients with endothelial 
dysfunction (RHI  <1.67) 
• IMR value according to the tertile of RHI  
Secondary outcome measures 
1. The relation between RHI values and:  
• The extent of myocardial necrosis 
• The extent of coronary microvascular 
obstruction 
In the 1st 
EndoPAT 
(acute) 
In the 2nd 
EndoPAT 
(24-h) 
Results 
Secondary Outcomes (1st EndoPAT) 
Endothelial dysfunction and microvascular obstruction 
Variable 
Total 
Population 
Endothelial Dysfunction (RHI<1.67) 
p value 
No (n=49) Yes (n=11) 
ECG 
   % ST resolution  
        Immediately after P-PCI b 74.5 (39.0) 74.0 (42.0) 77.0 (37.0) 0.83 
        90 min after P-PCI b 79.5 (32.0) 78.0 (34.0) 86.0 (25.0) 0.70 
   Residual total ST elevation 
        Immediately after P-PCI b 3.3 (6.0) 3.5 (6.0) 2.5 (6.0) 0.96 
        90 min after P-PCI b 1.5 (4.0) 1.5 (5.0) 1.5 (4.0) 0.77 
ceCMR 
   MVO present c  13 (26.5) 10 (25.6) 3 (30.0) 0.90 
Angiography 
   Corrected TIMI frame countb 17.0 (7.0) 18.0 (8.0) 14.0 (8.0) 0.27 
   TIMI myocardial perfusion grade 2-3c 49 (81.7) 38 (77.6) 11 (100.0) 0.24 
   Index of microvascular resistance b 23.9 (32.9) 24.0 (31.2) 16.0 (37.3) 0.17 
a Presented as mean±standard deviation; b Presented as median (interquartile range);  c Presented as number (%); 
Results 
Secondary Outcomes (2nd EndoPAT) 
Endothelial dysfunction and microvascular obstruction 
Variable 
Total 
Population 
Endothelial Dysfunction (RHI<1.67) 
p value 
No (n=22) Yes (n=16) 
ECG 
   % ST resolution  
        Immediately after P-PCI b 74.5 (39.0) 76.5 (41.0) 60.5 (72.0) 0.23 
        90 min after P-PCI b 77.0 (29.0) 78.5 (28.0) 69.0 (53.0) 0.07 
   Residual total ST elevation 
        Immediately after P-PCI b 3.0 (6.0) 2.5 (5.0) 5.0 (12.0) 0.048 
        90 min after P-PCI b 1.8 (4.0) 1.3 (4.0) 3.0 (7.0) 0.036 
ceCMR  (n=29)         
   MVO present c  8 (27.6%) 2 (11.1%) 6 (54.5%) 0.03 
Angiography         
   Corrected TIMI frame count b 17.0 (7.0) 16.4 (7.0) 19.5 (12.0) 0.07 
   TIMI myocardial perfusion grade 2-3c 28 (73.7%) 19 (86.4%) 9 (56.3%) 0.09 
   Index of microvascular resistance b 23.4 (35.2) 22.0 (26.0) 40.5 (54.4) 0.09 
a Presented as mean±standard deviation; b Presented as median (interquartile range);  c Presented as number (%); 
Results 
Secondary Outcomes (2nd EndoPAT) 
Endothelial dysfunction, microvascular obstruction and infarct 
extension 
Baptista SB et al.  Revista Portuguesa de Cardiologia; 2017; xxx:xxx 
Results 
Outcome measures 
Primary outcome measures 
• IMR value in patients with endothelial 
dysfunction (RHI  <1.67) 
• IMR value according to the tertile of RHI  
Secondary outcome measures 
1. The relation between RHI values and:  
• The extent of myocardial necrosis 
• The extent of coronary microvascular 
obstruction 
2. The relation between IMR values and: 
• The extent of myocardial necrosis 
• The extent of coronary microvascular 
obstruction 
Results 
Secondary Outcomes (IMR) 
IMR and infarct extension 
a mean±standard deviation; b median (interquartile range); d  number (%); 
Variable 
Total 
Population 
IMR > 24 
p value 
No (n=30) Yes (n=30) 
Troponin Release 
   TnIpeak  
a 117±82 91±59 142±93 0.013 
   TnIAUC  
a 1938±1283 1459±898 2418±1438 0.003 
Echocardiography 3 months         
   LVEF (%)a 52.6±7.1 54.6±6.5 50.1±7.1 0.024 
   Wall motion score index b 1.24 (0.35) 1.21±0.18 1.43±0.25 <0.001 
   Global longitudinal strain a -15.77±3.11 -16.81±1.86 -14.50±3.83 0.007 
ceCMR (n=49)         
   LVEF (%)a 53.6±8.7 54.2±9.0 52.8±9.0 0.59 
   Wall motion score index a 1.42±0.29 1.34±0.31 1.53±0.23 0.026 
   Transmural necrosis c 23 (46.9) 8 (27.6) 15 (75.0) 0.001 
   Infarct mass b 14.7 (12.6) 11.4 (10.9) 17.6 (15.0) 0.031 
   Percent infarct mass b 12.6 (14.4) 11.6 (12.1) 17.0 (15.4) 0.035 
Results 
Secondary Outcomes (IMR) 
IMR and left ventricular remodelling  
Difference between initial (acute) and follow up (3 months) Echo parameters according to median IMR  
a mean±standard deviation; b median (interquartile range); c  p-value for the comparison between the 2 echos 
IMR < 24 IMR > 24 
Echo parameters Echo1 Echo2 P valuec Echo1 Echo2 P valuec 
2D measurements   n=22     n=23   
   LVEdV (ml) a 102.5±23.9 101.2±20.3 0.78 108.3±26.0 118.3±32.1 0.043 
   LVEsV (ml) a 51.5±12.0 45.3±11.5 0.01 56.8±12.8 60.7±23.0 0.29 
   LVEF (%)a 49.4±6.6 55.4±5.1 0.001 47.3±5.2 49.7±6.8 0.13 
   WMSI b 1.41 (0.32) 1.12 (0.12) <0.001 1.41 (0.35) 1.35 (0.41) 0.010 
   Left atria (ml/m2) a 34.7±13.6 37.9±16.8 0.08 34.0±10.3 41.4±16.6 0.026 
Doppler measurements    n=18     n=19   
   E/A' ratio a 1.01±0.34 1.14±0.33 0.08 0.97±0.35 1.14±0.64 0.13 
   E/e’ ratio a  9.0±3.3 7.3±2.7 0.005 9.0±2.3 10.6±3.7 0.03 
2D speckle tracking imaging   n=16     n=19   
   Global longitudinal strain a -14.6±1.4 -17.2±1.3 <0.001 -13.3±2.4 -14.4±3.6 0.10 
Results 
Secondary Outcomes (IMR) 
IMR and left ventricular remodelling  
Difference between initial (acute) and follow up (3 months) Echo parameters according to median IMR  
Mariana Faustino, Baptista SB et al. J Interven Cardiol 2016;29:137–145 
Journal of Interventional Cardiology, 2016  
Results 
Secondary Outcomes (IMR) 
IMR and microvascular obstruction 
a median (interquartile range); b  number (%); 
Variable 
Total 
Population 
IMR > 24 
p value 
No (n=30) Yes (n=30) 
 ECG – ST resolution (%) 
      Immediately after P-PCI b 74.5 (39.0) 79.0 (33.0) 52.5 (79.0) 0.02 
      90 min b 79.5 (32.0) 86.5 (29.0) 75.5 (36.0) 0.014 
      180 min b 84.5 (23.0) 90.0 (23.0) 81.5 (40.0) 0.048 
Angiographic indicators  
      cTFC a 17.0 (7.0) 14.0 (7.0) 20.0 (10.0) <0.001 a 
      TMPG 2-3 b 49 (81.7) 28 (93.3) 21 (70.0) 0.019 b 
ceCMR (n=49) 
      MVO present b 13 (26.5) 4 (13.8) 9 (45.0) 0.015 
      Mass of MVO a 5.7 (4.0) 2.9 (2.9) 6.4 (11.5) 0.006 
Baptista SB et al. Accepted – TCT 2017, Denver, Colorado, USA 
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Conclusions 
Results Conc usions 
Main findings of the study 
• RHI measurement with EndoPAT immediately after primary PCI in ST 
elevation myocardial infarction patients probably cannot be 
performed, due to the serious unavoidable technical pitfalls in the 
acute phase.  
• RHI measurement with EndoPAT 24 hours after primary PCI in STEMI 
patients is feasible and related both to the extension of the infarct and 
to microvascular obstruction (including a tendency for lower IMR 
values in patients with higher RHI values).  
• IMR measured immediately after primary PCI in STEMI patients predicts 
MVO  and infarct extension - remodelling 
Results Conc usions 
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Limitations and Strengths 
Results Limitations and Strengths  
Limitations  
• Inclusion rate was very low and the cohort included 
represents only 11% of the population of patients with 
STEMI 
• EndoPAT exams were not performed according to the 
recommendations for endothelial function evaluation 
• The number of patients with the second EndoPAT evaluation 
is small 
• Imaging exams (both ceCMR and echocardiograms) are not 
available for all patients. 
Results Limitations and Strengths  
Strengths 
• One of the world’s largest single-centre databases in IMR 
evaluation in STEMI patient. 
• Systematically evaluating all indirect indicators of 
microvascular reperfusion. 
• Evaluation of myocardial infarction by troponin release was 
also much more comprehensive 
• Echo evaluation both acutely and at follow-up and using all 
available modes, including speckle-tracking analysis 
